This is 81% CR in patients who had already had recurrence and progression after front-line treatment, so neither of your concerns about the headline are relevant to the actual story.
The former point you made simply isn't addressed by the study, and the latter point effectively increases the percentage of patients that can be put in full remission; you're right, it's not 82% of all NMIBC cases, it's a superset of that number.
My point was that the title didn't contain enough context. The examples of 'improved' titles were purely demonstrative of titles that have some extra context to motivate what is special about this treatment - as in they are just made up to show what a good title would provide to give more context. You are missing the point completely.
